Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study

P. Toušek, V. Kočka, M. Malý, L. Lisa, T. Buděšínský, P. Widimský,

. 2016 ; 31 (6) : 841-5. [pub] 20150421

Jazyk angličtina Země Japonsko

Typ dokumentu klinická studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17024249
E-zdroje Online Plný text

NLK ProQuest Central od 2000-01-01 do 2018-12-31
Medline Complete (EBSCOhost) od 2003-03-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2000-01-01 do 2018-12-31

Incomplete stent apposition and uncovered struts are associated with a higher risk of stent thrombosis. No data exist on the process of neointimal coverage and late apposition status of the bioresorbable vascular scaffold (BVS) when implanted in the highly thrombogenic setting of ST-segment elevation acute myocardial infarction (STEMI). The aim of this study was to assess the serial changes in strut apposition and early neointimal coverage of the BVS using optical coherence tomography (OCT) in selected patients enrolled in the PRAGUE-19 study. Intracoronary OCT was performed in 50 patients at the end of primary percutaneous coronary intervention for acute STEMI. Repeated OCT of the implanted BVS was performed in 10 patients. Scaffold area, scaffold mean diameter and incomplete strut apposition (ISA) were compared between baseline and control OCT. Furthermore, strut neointimal coverage was assessed during the control OCT. Mean scaffold area and diameter did not change between the baseline and control OCT (8.59 vs. 9.06 mm(2); p = 0.129 and 3.31 vs. 3.37 mm; p = 0.202, respectively). Differences were observed in ISA between the baseline and control OCT (0.63 vs. 1.47 %; p < 0.05). We observed 83.1 % covered struts in eight patients in whom the control OCT was performed 4-6 weeks after BVS implantation, and 100 % covered struts in two patients 6 months after BVS implantation. Persistent strut apposition and early neointimal coverage were observed after biodegradable vascular scaffold implantation in patients with acute ST-segment elevation myocardial infarction.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17024249
003      
CZ-PrNML
005      
20170831115949.0
007      
ta
008      
170720s2016 ja f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00380-015-0679-8 $2 doi
035    __
$a (PubMed)25896128
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ja
100    1_
$a Toušek, Petr $u Third Faculty of Medicine, Cardiocenter, Charles University in Prague, University Hospital Kralovske Vinohrady, Ruska 87, 100 00, Prague, Czech Republic.
245    10
$a Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study / $c P. Toušek, V. Kočka, M. Malý, L. Lisa, T. Buděšínský, P. Widimský,
520    9_
$a Incomplete stent apposition and uncovered struts are associated with a higher risk of stent thrombosis. No data exist on the process of neointimal coverage and late apposition status of the bioresorbable vascular scaffold (BVS) when implanted in the highly thrombogenic setting of ST-segment elevation acute myocardial infarction (STEMI). The aim of this study was to assess the serial changes in strut apposition and early neointimal coverage of the BVS using optical coherence tomography (OCT) in selected patients enrolled in the PRAGUE-19 study. Intracoronary OCT was performed in 50 patients at the end of primary percutaneous coronary intervention for acute STEMI. Repeated OCT of the implanted BVS was performed in 10 patients. Scaffold area, scaffold mean diameter and incomplete strut apposition (ISA) were compared between baseline and control OCT. Furthermore, strut neointimal coverage was assessed during the control OCT. Mean scaffold area and diameter did not change between the baseline and control OCT (8.59 vs. 9.06 mm(2); p = 0.129 and 3.31 vs. 3.37 mm; p = 0.202, respectively). Differences were observed in ISA between the baseline and control OCT (0.63 vs. 1.47 %; p < 0.05). We observed 83.1 % covered struts in eight patients in whom the control OCT was performed 4-6 weeks after BVS implantation, and 100 % covered struts in two patients 6 months after BVS implantation. Persistent strut apposition and early neointimal coverage were observed after biodegradable vascular scaffold implantation in patients with acute ST-segment elevation myocardial infarction.
650    12
$a vstřebatelné implantáty $7 D020341
650    _2
$a senioři $7 D000368
650    _2
$a kardiovaskulární látky $x aplikace a dávkování $x škodlivé účinky $7 D002317
650    12
$a biokompatibilní potahované materiály $7 D020099
650    _2
$a koronární angiografie $7 D017023
650    _2
$a koronární cévy $x diagnostické zobrazování $x účinky léků $7 D003331
650    _2
$a Česká republika $7 D018153
650    _2
$a everolimus $x aplikace a dávkování $x škodlivé účinky $7 D000068338
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a neointima $7 D058426
650    _2
$a koronární angioplastika $x škodlivé účinky $x přístrojové vybavení $7 D062645
650    _2
$a prospektivní studie $7 D011446
650    _2
$a protézy - design $7 D011474
650    _2
$a infarkt myokardu s elevacemi ST úseků $x diagnostické zobrazování $x terapie $7 D000072657
650    _2
$a časové faktory $7 D013997
650    _2
$a optická koherentní tomografie $7 D041623
650    _2
$a výsledek terapie $7 D016896
655    _2
$a klinická studie $7 D000068397
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kočka, Viktor $u Third Faculty of Medicine, Cardiocenter, Charles University in Prague, University Hospital Kralovske Vinohrady, Ruska 87, 100 00, Prague, Czech Republic. viktor.kocka@fnkv.cz.
700    1_
$a Malý, Martin $u First Faculty of Medicine, Cardiovascular Center, Charles University in Prague, Central Military Hospital Prague, Prague, Czech Republic.
700    1_
$a Lisa, Libor $u Third Faculty of Medicine, Cardiocenter, Charles University in Prague, University Hospital Kralovske Vinohrady, Ruska 87, 100 00, Prague, Czech Republic.
700    1_
$a Buděšínský, Tomáš $u Third Faculty of Medicine, Cardiocenter, Charles University in Prague, University Hospital Kralovske Vinohrady, Ruska 87, 100 00, Prague, Czech Republic.
700    1_
$a Widimský, Petr $u Third Faculty of Medicine, Cardiocenter, Charles University in Prague, University Hospital Kralovske Vinohrady, Ruska 87, 100 00, Prague, Czech Republic.
773    0_
$w MED00009797 $t Heart and vessels $x 1615-2573 $g Roč. 31, č. 6 (2016), s. 841-5
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25896128 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170831120539 $b ABA008
999    __
$a ok $b bmc $g 1239930 $s 985162
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 31 $c 6 $d 841-5 $e 20150421 $i 1615-2573 $m Heart and vessels $n Heart Vessels $x MED00009797
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...